Show notes
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
Semaglutide, the ingredient behind weekly injections for diabetes and weight management, lost its main patent in India this year, and a dozen or so companies launched their own versions almost overnight. The seventh episode of Pharma Explained looks at what has changed for prices, brands and patients, and how the same patent expiry is playing out in other countries.
We’ll cover:
• How the generic launch has changed what patients can buy and what it costs.
• How the original makers have…
Website: rss.com

